Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 38
Filter
1.
Arthritis Rheumatol ; 75(2): 220-231, 2023 02.
Article in English | MEDLINE | ID: mdl-36577442

ABSTRACT

OBJECTIVE: We undertook this study to examine the functional basis for epistasis between endoplasmic reticulum aminopeptidase 1 (ERAP1) and HLA-B27 in experimental spondyloarthritis (SpA). METHODS: ERAP1-knockout rats were created using genome editing and bred with HLA-B27/human ß2 -microglobulin-transgenic (HLA-B27-Tg) rats and HLA-B7-Tg rats. The effects of ERAP1 deficiency on HLA allotypes were determined using immunoprecipitation and immunoblotting, flow cytometry, allogeneic T cell proliferation assays, and gene expression analyses. Animals were examined for clinical features of disease, and tissue was assessed by histology. RESULTS: ERAP1 deficiency increased the ratio of folded to unfolded (ß2 m-free) HLA-B27 heavy chains, while having the opposite effect on HLA-B7. Furthermore, in rats with ERAP1 deficiency, HLA-B27 misfolding was reduced, while free HLA-B27 heavy chain dimers on the cell surface and monomers were increased. The effects of ERAP1 deficiency persisted during up-regulation of HLA-B27 and led to a reduction in endoplasmic reticulum stress. ERAP1 deficiency reduced the prevalence of arthritis in HLA-B27-Tg rats by two-thirds without reducing gastrointestinal inflammation. Dendritic cell abnormalities attributed to the presence of HLA-B27, including reduced allogeneic T cell stimulation and loss of CD103-positive/major histocompatibility complex class II-positive cells, were not rescued by ERAP1 deficiency, while excess Il23a up-regulation was mitigated. CONCLUSION: ERAP1 deficiency reduced HLA-B27 misfolding and improved folding while having opposing effects on HLA-B7. The finding that HLA-B27-Tg rats had partial protection against SpA in this study is consistent with genetic evidence that loss-of-function and/or reduced expression of ERAP1 reduces the risk of ankylosing spondylitis. Functional studies support the concept that the effects of ERAP1 on HLA-B27 and SpA may be a consequence of how peptides affect the biology of this allotype rather than their role as antigenic determinants.


Subject(s)
HLA-B27 Antigen , Spondylitis, Ankylosing , Animals , Humans , Rats , Aminopeptidases/genetics , Aminopeptidases/metabolism , Endoplasmic Reticulum/metabolism , HLA-B27 Antigen/genetics , HLA-B27 Antigen/metabolism , HLA-B7 Antigen , Minor Histocompatibility Antigens/genetics , Spondylitis, Ankylosing/genetics , Arthritis/genetics , Arthritis/metabolism
2.
J Exp Bot ; 73(1): 78-93, 2022 01 05.
Article in English | MEDLINE | ID: mdl-34460901

ABSTRACT

Plant endosymbiotic organelles such as mitochondria and chloroplasts harbour a wide array of biochemical reactions. As a part of protein homeostasis to maintain organellar activity and stability, unwanted proteins and peptides need to be completely degraded in a stepwise mechanism termed the processing pathway, where at the last stage single amino acids are released by aminopeptidases. Here, we determined the molecular and physiological functions of a prolyl aminopeptidase homologue PAP1 (At2g14260) that is able to release N-terminal proline. Transcript analyses demonstrate that an alternative transcription start site gives rise to two alternative transcripts, generating two in-frame proteins PAP1.1 and PAP1.2. Subcellular localization studies revealed that the longer isoform PAP1.1, which contains a 51 residue N-terminal extension, is exclusively targeted to chloroplasts, while the truncated isoform PAP1.2 is located in the cytosol. Distinct expression patterns in different tissues and developmental stages were observed. Investigations into the physiological role of PAP1 using loss-of-function mutants revealed that PAP1 activity may be involved in proline homeostasis and accumulation, required for pollen development and tolerance to osmotic stress. Enzymatic activity, subcellular location, and expression patterns of PAP1 suggest a role in the chloroplastic peptide processing pathway and proline homeostasis.


Subject(s)
Arabidopsis Proteins , Arabidopsis , Aminopeptidases/genetics , Pollen , Proline
3.
Plant J ; 104(5): 1182-1194, 2020 12.
Article in English | MEDLINE | ID: mdl-32920905

ABSTRACT

Most mitochondrial proteins are synthesised in the cytosol and targeted into the organelle via N-terminal targeting peptides that are cleaved upon import. The free targeting peptide is subsequently processed in a stepwise manner, with single amino acids released as final products. Here, we have characterised a proline-cleaving aminopeptidase in Arabidopsis thaliana, prolyl aminopeptidase-2 (PAP2, At3g61540). Activity assays show that PAP2 has a preferred activity to hydrolyse N-terminal proline. Protein localisation studies revealed that PAP2 is exclusively targeted to mitochondria. Characterisation of pap2 mutants show defective pollen, enhanced dark-induced senescence and increased susceptibility to abiotic stresses, which are likely attributed to a reduced level of accumulated free proline. Taken together, these results demonstrate the role of PAP2 in proline cleavage from mitochondrial peptides and proline homeostasis, which is required for the development of male gametophyte, tolerance to abiotic stresses, and leaf senescence.


Subject(s)
Aminopeptidases/metabolism , Arabidopsis Proteins/metabolism , Arabidopsis/metabolism , Proline/metabolism , Stress, Physiological/physiology , Transcription Factors/metabolism , Amino Acid Motifs , Aminopeptidases/genetics , Arabidopsis/cytology , Arabidopsis/genetics , Arabidopsis Proteins/genetics , Cellular Senescence/physiology , Darkness , Green Fluorescent Proteins/genetics , Loss of Function Mutation , Mitochondria/metabolism , Phylogeny , Plants, Genetically Modified , Pollen/physiology , Transcription Factors/genetics
4.
Gut ; 67(2): 271-283, 2018 02.
Article in English | MEDLINE | ID: mdl-28377388

ABSTRACT

OBJECTIVE: To investigate the beneficial role of prebiotics on endothelial dysfunction, an early key marker of cardiovascular diseases, in an original mouse model linking steatosis and endothelial dysfunction. DESIGN: We examined the contribution of the gut microbiota to vascular dysfunction observed in apolipoprotein E knockout (Apoe-/-) mice fed an n-3 polyunsaturated fatty acid (PUFA)-depleted diet for 12 weeks with or without inulin-type fructans (ITFs) supplementation for the last 15 days. Mesenteric and carotid arteries were isolated to evaluate endothelium-dependent relaxation ex vivo. Caecal microbiota composition (Illumina Sequencing of the 16S rRNA gene) and key pathways/mediators involved in the control of vascular function, including bile acid (BA) profiling, gut and liver key gene expression, nitric oxide and gut hormones production were also assessed. RESULTS: ITF supplementation totally reverses endothelial dysfunction in mesenteric and carotid arteries of n-3 PUFA-depleted Apoe-/- mice via activation of the nitric oxide (NO) synthase/NO pathway. Gut microbiota changes induced by prebiotic treatment consist in increased NO-producing bacteria, replenishment of abundance in Akkermansia and decreased abundance in bacterial taxa involved in secondary BA synthesis. Changes in gut and liver gene expression also occur upon ITFs suggesting increased glucagon-like peptide 1 production and BA turnover as drivers of endothelium function preservation. CONCLUSIONS: We demonstrate for the first time that ITF improve endothelial dysfunction, implicating a short-term adaptation of both gut microbiota and key gut peptides. If confirmed in humans, prebiotics could be proposed as a novel approach in the prevention of metabolic disorders-related cardiovascular diseases.


Subject(s)
Endothelium, Vascular/drug effects , Endothelium, Vascular/physiopathology , Fructans/pharmacology , Gastrointestinal Microbiome/drug effects , Prebiotics , Aminopeptidases/genetics , Animals , Antimicrobial Cationic Peptides/genetics , Bacteria/drug effects , Bile Acids and Salts/biosynthesis , Bile Acids and Salts/blood , Carotid Arteries/physiology , Cecum/microbiology , Dietary Supplements , Disease Models, Animal , Fatty Acids, Omega-3/administration & dosage , Fatty Acids, Omega-3/deficiency , Gene Expression/drug effects , Glucagon-Like Peptide 1/biosynthesis , Male , Mesenteric Arteries/physiology , Mice , Mice, Inbred C57BL , Mice, Knockout, ApoE , Neurotensin/genetics , Nitric Oxide/metabolism , Nitric Oxide Synthase/metabolism , Organic Anion Transporters, Sodium-Dependent/genetics , Proglucagon/genetics , Symporters/genetics , Vasodilation
5.
Can J Microbiol ; 63(6): 516-524, 2017 Jun.
Article in English | MEDLINE | ID: mdl-28257579

ABSTRACT

To investigate the physiological role of an extracellular aminopeptidase (BSAP168) encoded by the ywaD gene in Bacillus subtilis 168, we constructed the ywaD-deletion mutant (BS-AP-K). Compared with that of the wild-type strain, the maximum growth rate of BS-AP-K was reduced by 28% when grown in soybean protein medium at 37 °C, but not in Luria-Bertani medium. The impaired growth rate was more marked at higher temperature and could be compensated by supplementation of amino acid to the culture media. Further studies showed that in regards to the amino acid compositions and peptide distribution in the culture supernatants, there was an obvious difference between the culture supernatants of wild-type and BS-AP-K strains. In addition, another mutant strain (BS-AP-R) was constructed by replacing ywaD with ywaD-ΔPA to evaluate the effect of a protease-associated domain in BSAP168 on growth. All these findings indicated that BSAP168 played an important role in supplying the amino acids required for growth.


Subject(s)
Aminopeptidases/genetics , Bacillus subtilis/enzymology , Bacterial Proteins/genetics , Amino Acids , Aminopeptidases/metabolism , Bacillus subtilis/genetics , Bacillus subtilis/growth & development , Bacterial Proteins/metabolism , Nitrogen/metabolism
6.
Endocrinology ; 157(8): 3253-65, 2016 08.
Article in English | MEDLINE | ID: mdl-27323240

ABSTRACT

Hypothalamic-pituitary-thyroid (HPT) axis activity is important for energy homeostasis, and is modified by stress. Maternal separation (MS) alters the stress response and predisposes to metabolic disturbances in the adult. We therefore studied the effect of MS on adult HPT axis activity. Wistar male and female pups were separated from their mothers 3 h/d during postnatal day (PND)2-PND21 (MS), or left nonhandled (NH). Open field and elevated plus maze tests revealed increased locomotion in MS males and anxiety-like behavior in MS females. At PND90, MS females had increased body weight gain, Trh expression in the hypothalamic paraventricular nucleus, and white adipose tissue mass. MS males had increased expression of TRH-degrading enzyme in tanycytes, reduced TSH and T3, and enhanced corticosterone serum concentrations. MS stimulated brown adipose tissue deiodinase 2 activity in either sex. Forty-eight hours of fasting (PND60) augmented serum corticosterone levels similarly in MS or NH females but more in MS than in NH male rats. MS reduced the fasting-induced drop in hypothalamic paraventricular nucleus-Trh expression of males but not of females and abolished the fasting-induced increase in Trh expression in both sexes. Fasting reduced serum concentrations of TSH, T4, and T3, less in MS than in NH males, whereas in females, TSH decreased in MS but not in NH rats, but T4 and T3 decreased similarly in NH and MS rats. In conclusion, MS produced long-term changes in the activity of the HPT axis that were sex specific; response to fasting was partially blunted in males, which could affect their adaptive response to negative energy balance.


Subject(s)
Aminopeptidases/genetics , Hypothalamus/metabolism , Maternal Deprivation , Pyrrolidonecarboxylic Acid/analogs & derivatives , Starvation/physiopathology , Thyroid Gland/physiology , Thyrotropin-Releasing Hormone/genetics , Aminopeptidases/metabolism , Animals , Animals, Newborn , Female , Male , Pyrrolidonecarboxylic Acid/metabolism , Rats , Rats, Wistar , Sex Characteristics , Starvation/genetics , Starvation/metabolism , Thyrotropin-Releasing Hormone/metabolism
7.
Adv Clin Exp Med ; 25(1): 117-28, 2016.
Article in English | MEDLINE | ID: mdl-26935506

ABSTRACT

BACKGROUND: Methionine aminopeptidase 2 (MetAP2) is a bi-functional protein that plays a critical role in the regulation of post-translational processing and protein synthesis. OBJECTIVES: We studied whether MetAP2 is activated and expressed in human non-small-cell lung cancer (NSCLC) tissues and whether inactivation of MetAP2 activity, with its specific inhibitor fumagillin, potentially inhibits proliferation of NSCLC cells. MATERIAL AND METHODS: The expression and function of MetAP2 were evaluated in NSCLC tissues, primary cell cultures and cell lines using immunohistochemistry, RT-PCR, Western blot, aminopeptidase activity assay and flow cytometry. MetAP2 expression was also studied in relation to clinicopathological factors. RESULTS: MetAP2 expression in NSCLS, including adenocarcinoma (ADC) and squamous cell carcinoma (SCC), showed a moderate to strong positive reaction while normal appearing bronchial epithelium showed weak staining and normal alveolar epithelial cells were widely negative. A high MetAP2 mRNA and protein expression was found in NSCLC tissues. The aminopeptidase activity in NSCLC was 2-fold higher than that in normal lung tissues. In a series of 41 ADC patients, MetAP2 expression was significantly correlated with patient's outcome or survival time. Inhibition of MetAP2 by fumagillin in SCC cell lines revealed a significant increase in caspase-3 activity as compared to the control (p = 0.001). CONCLUSIONS: Our results indicate that MetAP2 is involved in NSCLC and is an important regulator of proliferative and apoptotic targets. Thus inhibition of MetAP2, such as by fumagillin, may be a potential therapeutic modality for prevention of tumor cell growth, development and progression in NSCLC patients.


Subject(s)
Adenocarcinoma/enzymology , Aminopeptidases/metabolism , Biomarkers, Tumor/metabolism , Carcinoma, Non-Small-Cell Lung/enzymology , Carcinoma, Squamous Cell/enzymology , Glycoproteins/metabolism , Lung Neoplasms/enzymology , Adenocarcinoma/drug therapy , Adenocarcinoma/genetics , Adenocarcinoma/pathology , Adenocarcinoma of Lung , Aged , Aged, 80 and over , Aminopeptidases/antagonists & inhibitors , Aminopeptidases/genetics , Antineoplastic Agents/pharmacology , Apoptosis/drug effects , Biomarkers, Tumor/antagonists & inhibitors , Biomarkers, Tumor/genetics , Carcinoma, Non-Small-Cell Lung/drug therapy , Carcinoma, Non-Small-Cell Lung/genetics , Carcinoma, Non-Small-Cell Lung/pathology , Carcinoma, Squamous Cell/drug therapy , Carcinoma, Squamous Cell/genetics , Carcinoma, Squamous Cell/pathology , Cell Line, Tumor , Cell Proliferation/drug effects , Cyclohexanes/pharmacology , Enzyme Inhibitors/pharmacology , Fatty Acids, Unsaturated/pharmacology , Female , Gene Expression Regulation, Enzymologic , Gene Expression Regulation, Neoplastic , Glycoproteins/antagonists & inhibitors , Glycoproteins/genetics , Humans , Lung Neoplasms/drug therapy , Lung Neoplasms/genetics , Lung Neoplasms/pathology , Male , Methionyl Aminopeptidases , Middle Aged , Molecular Targeted Therapy , Sesquiterpenes/pharmacology , Signal Transduction/drug effects , Tumor Cells, Cultured , Up-Regulation
8.
Protein Expr Purif ; 122: 23-30, 2016 06.
Article in English | MEDLINE | ID: mdl-26898926

ABSTRACT

Aminopeptidases are widely used for creating protein hydrolysates and peptide sequencing. The ywaD gene from a new Bacillus isolate, named Bacillus subtilis subsp. subtilis str. BSP1, was cloned into the yeast expression vector pHBM905A and expressed and secreted by Pichia pastoris strain GS115. The deduced amino acid sequence of the aminopeptidase encoded by the ywaD gene shared up to 98% identity with aminopeptidases from B. subtilis strains 168 and zj016. The yield (3.81 g/l) and specific activity (788 U/mg) of recombinant YwaD in high-density fermentation were extremely high. And 829.83 mg of the purified enzyme (4089.72 U/mg) were harvested. YwaD was glycosylated, and its activity decreased after deglycosylation, which was similar to that of the aminopeptidase from B. subtilis strain zj016. YwaD was most active toward l-arginine-4-nitroanilide. Moreover, it exhibited high resistance to carbamide, which was not true for aminopeptidases from B. subtilis strains 168 and zj016, which could simplify the purification of YwaD. Moreover, the expression and parts of characterization of the aminopeptidase from B. subtilis strain 168 in Pichia pastoris were added as supplementary material. The sequence and other characteristics of YwaD were compared with those of aminopeptidases from B. subtilis strains 168 and zj016, and they will provide a solid foundation for further research on the influence of amino acid mutations on the function of aminopeptidases.


Subject(s)
Aminopeptidases/genetics , Aminopeptidases/metabolism , Bacillus subtilis/enzymology , Bacillus subtilis/genetics , Cloning, Molecular/methods , Pichia/genetics , Amino Acid Sequence , Aminopeptidases/chemistry , Aminopeptidases/isolation & purification , Bacillus subtilis/chemistry , Bacillus subtilis/metabolism , Fermentation , Glycosylation , Hydrogen-Ion Concentration , Recombinant Proteins/chemistry , Recombinant Proteins/genetics , Recombinant Proteins/isolation & purification , Recombinant Proteins/metabolism , Sequence Alignment
9.
Endocrinology ; 156(7): 2713-23, 2015 Jul.
Article in English | MEDLINE | ID: mdl-25942072

ABSTRACT

Fasting down-regulates the hypothalamus-pituitary-thyroid (HPT) axis activity through a reduction of TRH synthesis in neurons of the parvocellular paraventricular nucleus of the hypothalamus (PVN). These TRH neurons project to the median eminence (ME), where TRH terminals are close to the cytoplasmic extensions of ß2 tanycytes. Tanycytes express pyroglutamyl peptidase II (PPII), the TRH-degrading ectoenzyme that controls the amount of TRH that reaches the anterior pituitary. We tested the hypothesis that regulation of ME PPII activity is another mechanism by which fasting affects the activity of the HPT axis. Semiquantitative in situ hybridization histochemistry data indicated that PPII and deiodinase 2 mRNA levels increased in tanycytes after 48 hours of fasting. This increase was transitory, followed by an increase of PPII activity in the ME, and a partial reversion of the reduction in PVN pro-TRH mRNA levels and the number of TRH neurons detected by immunohistochemistry. In fed animals, adrenalectomy and corticosterone treatment did not change ME PPII activity 72 hours later. Methimazole-induced hypothyroidism produced a profound drop in tanycytes PPII mRNA levels, which was reverted by 3 days of treatment with T4. The activity of thyroliberinase, the serum isoform of PPII, was increased at most fasting time points studied. We conclude that delayed increases in both the ME PPII as well as the thyroliberinase activities in fasted male rats may facilitate the maintenance of the deep down-regulation of the HPT axis function, despite a partial reactivation of TRH expression in the PVN.


Subject(s)
Aminopeptidases/genetics , Ependymoglial Cells/enzymology , Fasting/metabolism , Hypothalamo-Hypophyseal System/metabolism , Hypothalamus/metabolism , Median Eminence/metabolism , Pyrrolidonecarboxylic Acid/analogs & derivatives , RNA, Messenger/metabolism , Thyrotropin-Releasing Hormone/metabolism , Adrenalectomy , Aminopeptidases/drug effects , Aminopeptidases/metabolism , Animals , Antithyroid Agents/pharmacology , Corticosterone/pharmacology , Ependymoglial Cells/drug effects , Ependymoglial Cells/metabolism , Hypothalamus/cytology , Hypothalamus/drug effects , Hypothyroidism , Iodide Peroxidase/genetics , Male , Methimazole/pharmacology , Paraventricular Hypothalamic Nucleus/cytology , Paraventricular Hypothalamic Nucleus/drug effects , Paraventricular Hypothalamic Nucleus/metabolism , Protein Precursors/genetics , Pyrrolidonecarboxylic Acid/metabolism , RNA, Messenger/drug effects , Rats , Thyrotropin-Releasing Hormone/drug effects , Thyrotropin-Releasing Hormone/genetics , Thyroxine/pharmacology , Iodothyronine Deiodinase Type II
10.
Prog Retin Eye Res ; 44: 99-110, 2015 Jan.
Article in English | MEDLINE | ID: mdl-25434765

ABSTRACT

Birdshot chorioretinopathy (BSCR) is a bilateral chronic intraocular inflammation or posterior uveitis that preferentially affects middle-aged Caucasians. BSCR is characterized by distinctive multiple choroidal hypopigmented lesions in combination with retinal vasculitis and vitritis, and the extraordinary feature that virtually all patients are HLA-A29 positive. Its pathophysiology is still poorly understood. BSCR is the strongest documented association between HLA and disease in humans, which makes it an excellent model for studying the underlying immuno-genetic mechanisms of HLA class I-associated diseases. Although the association with HLA-A29 suggests that it is directly involved in the presentation of peptide antigens to T cells, the exact contribution of HLA-A29 to the pathophysiology of BSCR remains enigmatic. This article revisits the HLA-A29 peptidome using insights from recent studies and discusses why HLA-A29 can be considered a canonical antigen presenting molecule. The first genome-wide association study facilitated novel concepts into a disease mechanism beyond HLA-A29 that includes strong genetic predisposition for the ERAP2 gene that affects antigen processing for HLA class I. Furthermore, patients manifest with pro-inflammatory cytokine profiles and pathogenic T cell subsets that are associated with IL-17-linked inflammation. We are beginning to understand that the underlying biology of BSCR comprises various pathologic aspects branched into multiple molecular pathways. We propose to employ Systems Medicine to reveal their dynamic interplay for a holistic view of the immunopathology of this intriguing archetypal HLA class I-associated disease.


Subject(s)
Chorioretinitis , Aminopeptidases/genetics , Aminopeptidases/physiology , Animals , Autoimmunity , Birdshot Chorioretinopathy , Chorioretinitis/genetics , Chorioretinitis/immunology , Chorioretinitis/physiopathology , Disease Models, Animal , Genome-Wide Association Study , HLA-A Antigens/physiology , Humans , T-Lymphocytes/immunology , Th17 Cells/immunology
11.
Biochemistry (Mosc) ; 78(7): 721-5, 2013 Jul.
Article in English | MEDLINE | ID: mdl-24010835

ABSTRACT

The lysosomal storage disorders (LSD) represent a heterogeneous group of inherited diseases characterized by the accumulation of non-metabolized macromolecules (by-products of cellular turnover) in different tissues and organs. LSDs primarily develop as a consequence of a deficiency in a lysosomal hydrolase or its co-factor. The majority of these enzymes are glycosidases and sulfatases, which in normal conditions participate in degradation of glycoconjugates: glycoproteins, glycosaminoproteoglycans, and glycolipids. Significant insights have been gained from studies of animal models, both in understanding mechanisms of disease and in establishing proof of therapeutic concept. These studies have led to the introduction of therapy for certain LSD subtypes, primarily by enzyme replacement or substrate reduction therapy. Animal models have been useful in elucidating molecular changes, particularly prior to onset of symptoms. On the other hand, it should be noted certain animal (mouse) models may have the underlying biochemical defect, but not show the course of disease observed in human patients. There is interest in examining therapeutic options in the larger spontaneous animal models that may more closely mimic the brain size and pathology of humans. This review will highlight lessons learned from studies of animal models of disease, drawing primarily from publications in 2011-2012.


Subject(s)
Lysosomal Storage Diseases/metabolism , Aminopeptidases/genetics , Aminopeptidases/metabolism , Aminopeptidases/therapeutic use , Animals , Dipeptidyl-Peptidases and Tripeptidyl-Peptidases/genetics , Dipeptidyl-Peptidases and Tripeptidyl-Peptidases/metabolism , Dipeptidyl-Peptidases and Tripeptidyl-Peptidases/therapeutic use , Disease Models, Animal , Drug Evaluation, Preclinical , Glycogen Storage Disease Type II/drug therapy , Glycogen Storage Disease Type II/metabolism , Glycogen Storage Disease Type II/pathology , Humans , Lysosomal Storage Diseases/drug therapy , Lysosomal Storage Diseases/pathology , Niemann-Pick Disease, Type C/drug therapy , Niemann-Pick Disease, Type C/metabolism , Niemann-Pick Disease, Type C/pathology , Recombinant Proteins/biosynthesis , Recombinant Proteins/genetics , Recombinant Proteins/therapeutic use , Serine Proteases/genetics , Serine Proteases/metabolism , Serine Proteases/therapeutic use , Tripeptidyl-Peptidase 1 , alpha-Glucosidases/genetics , alpha-Glucosidases/metabolism , alpha-Glucosidases/therapeutic use
12.
Cell Biochem Biophys ; 67(3): 1353-63, 2013.
Article in English | MEDLINE | ID: mdl-23743710

ABSTRACT

Cadmium (Cd) is a potent toxic element used in several industries and in the process contaminates air, soil, and water. Exposure of Saccharomyces cerevisiae to Cd increases the major phospholipids, and profound increase was observed in phosphatidylethanolamine (PE). In yeast, there are four different pathways contributing to the biosynthesis of PE, and contribution to PE pool through phosphatidylserine decarboxylase2 (psd2) is not significant in normal conditions. Upon Cd exposure, psd2Δ strain showed a significant decrease in major phospholipids including PE. When exposed to Cd, wild-type (WT) cells depicted an increase in ER stress and autophagy, whereas in psd2, ER stress was noted but autophagy process was impaired. The supplementation of ethanolamine did not overcome the Cd stress and also the autophagy process, whereas overexpression of PSD2 in psd2Δ increased the cellular tolerance, PE levels, and the autophagy process against Cd stress. From our studies, we can suggest that PSD2 of S. cerevisiae has an important role in PE synthesis and in autophagy process under Cd stress.


Subject(s)
Autophagy/physiology , Cadmium/toxicity , Carboxy-Lyases/metabolism , Phosphatidylethanolamines/metabolism , Saccharomyces cerevisiae Proteins/metabolism , Saccharomyces cerevisiae/metabolism , Stress, Physiological/drug effects , Aminopeptidases/genetics , Aminopeptidases/metabolism , Autophagy/drug effects , Carboxy-Lyases/genetics , Ethanolamine/pharmacology , Saccharomyces cerevisiae/drug effects , Saccharomyces cerevisiae/enzymology , Saccharomyces cerevisiae Proteins/genetics
13.
PLoS One ; 7(4): e35388, 2012.
Article in English | MEDLINE | ID: mdl-22509410

ABSTRACT

Pulmonary Hypertension (PH) is a pathophysiologic condition characterized by hypoxemia and right ventricular strain. Proliferation of fibroblasts, smooth muscle cells, and endothelial cells is central to the pathology of PH in animal models and in humans. Methionine aminopeptidase-2 (MetAP2) regulates proliferation in a variety of cell types including endothelial cells, smooth muscle cells, and fibroblasts. MetAP2 is inhibited irreversibly by the angiogenesis inhibitor fumagillin. We have previously found that inhibition of MetAP2 with fumagillin in bleomycin-injured mice decreased pulmonary fibrosis by selectively decreasing the proliferation of lung myofibroblasts. In this study, we investigated the role of fumagillin as a potential therapy in experimental PH. In vivo, treatment of rats with fumagillin early after monocrotaline injury prevented PH and right ventricular remodeling by decreasing the thickness of the medial layer of the pulmonary arteries. Treatment with fumagillin beginning two weeks after monocrotaline injury did not prevent PH but was associated with decreased right ventricular mass and decreased cardiomyocyte hypertrophy, suggesting a direct effect of fumagillin on right ventricular remodeling. Incubation of rat pulmonary artery smooth muscle cells (RPASMC) with fumagillin and MetAP2-targeting siRNA inhibited proliferation of RPASMC in vitro. Platelet-derived growth factor, a growth factor that is important in the pathogenesis of PH and stimulates proliferation of fibroblasts and smooth muscle cells, strongly increased expression of MetP2. By immunohistochemistry, we found that MetAP2 was expressed in the lesions of human pulmonary arterial hypertension. We propose that fumagillin may be an effective adjunctive therapy for treating PH in patients.


Subject(s)
Aminopeptidases/metabolism , Cyclohexanes/administration & dosage , Fatty Acids, Unsaturated/administration & dosage , Glycoproteins/metabolism , Hypertension, Pulmonary/pathology , Hypertension, Pulmonary/prevention & control , Aminopeptidases/antagonists & inhibitors , Aminopeptidases/genetics , Animals , Cell Proliferation/drug effects , Cells, Cultured , Disease Models, Animal , Gene Expression Regulation , Glycoproteins/antagonists & inhibitors , Glycoproteins/genetics , Heart Ventricles/drug effects , Heart Ventricles/physiopathology , Hemodynamics , Humans , Hypertension, Pulmonary/chemically induced , Male , Monocrotaline/pharmacology , Myocytes, Cardiac/drug effects , Myocytes, Cardiac/metabolism , Myocytes, Smooth Muscle/cytology , Myofibroblasts/drug effects , Myofibroblasts/pathology , Platelet-Derived Growth Factor/genetics , Platelet-Derived Growth Factor/metabolism , Pulmonary Artery/cytology , Pulmonary Artery/drug effects , Rats , Rats, Sprague-Dawley , Sesquiterpenes/administration & dosage
14.
Planta ; 234(4): 857-63, 2011 Oct.
Article in English | MEDLINE | ID: mdl-21744092

ABSTRACT

The effects of cadmium (Cd) on aminopeptidase (AP) activities and Leucine-AP (LAP) expression were investigated in the roots of tomato (Solanum lycopersicum L., var Ibiza) plants. Three-week-old plants were grown for 10 days in the presence of 0.3-300 µM Cd and compared to control plants grown in the absence of Cd. AP activities were measured using six different p-nitroanilide (p-NA) substrates. Leu, Met, Arg, Pro and Lys hydrolyzing activities increased in roots of Cd-treated plants, while Phe-pNA cleavage was not enhanced after Cd treatments. The use of peptidase inhibitors showed that most of the Leu-pNA hydrolyzing activity was related to one or several metallo-APs. Changes in Lap transcripts, protein and activities were measured in the roots of 0 and 30-µM Cd-treated plants. LapA transcript levels increased in Cd-treated roots, whereas LapN RNAs levels were not modified. To assess amount of Leu-pNA hydrolyzing activity associated with the hexameric LAPs, LAP activity was measured following immunoprecipitation with a LAP polyclonal antiserum. LAP activity increased in Cd-treated roots. There was a corresponding increase in LAP-A protein levels detected in 2D-immunoblots. The role of LAP-A in the proteolytic response to Cd stress is discussed.


Subject(s)
Aminopeptidases/drug effects , Aminopeptidases/metabolism , Cadmium/pharmacology , Plant Roots/enzymology , Protease Inhibitors/pharmacology , Solanum lycopersicum/enzymology , Aminopeptidases/genetics , Gene Expression Regulation, Developmental , Gene Expression Regulation, Plant , Leucyl Aminopeptidase/drug effects , Leucyl Aminopeptidase/genetics , Leucyl Aminopeptidase/metabolism , Solanum lycopersicum/drug effects , Solanum lycopersicum/genetics , Solanum lycopersicum/metabolism , Plant Extracts , Plant Leaves/drug effects , Plant Leaves/enzymology , Plant Leaves/genetics , Plant Leaves/metabolism , Plant Roots/drug effects , Plant Roots/genetics , Plant Roots/metabolism , RNA, Plant/genetics , Seedlings/drug effects , Seedlings/enzymology , Seedlings/genetics , Seedlings/metabolism , Stress, Physiological , Substrate Specificity , Time Factors , Up-Regulation
15.
Biotechnol Bioeng ; 108(8): 1942-53, 2011 Aug.
Article in English | MEDLINE | ID: mdl-21351072

ABSTRACT

The yeast Pichia pastoris enables efficient (high titer) recombinant protein production. As the molecular tools required are well established and gene specific optimizations of transcription and translation are becoming available, metabolism moves into focus as possible limiting factor of recombinant protein production in P. pastoris. To investigate the impact of recombinant protein production on metabolism systematically, we constructed strains that produced the model protein ß-aminopeptidase BapA of Sphingosinicella xenopeptidilytica at different production yields. The impact of low to high BapA production on cell physiology was quantified. The data suggest that P. pastoris compensates for the additional resources required for recombinant protein synthesis by reducing by-product formation and by increasing energy generation via the TCA cycle. Notably, the activity of the TCA cycle was constant with a rate of 2.1 ± 0.1 mmol g CDW-1 h(-1) irrespective of significantly reduced growth rates in high BapA producing strains, suggesting an upper limit of TCA cycle activity. The reduced growth rate could partially be restored by providing all 20 proteinogenic amino acids in the fermentation medium. Under these conditions, the rate of BapA synthesis increased twofold. The successful supplementation of the growth medium by amino acids to unburden cellular metabolism during recombinant protein production suggests that the metabolic network is a valid target for future optimization of protein production by P. pastoris.


Subject(s)
Carbon/metabolism , Energy Metabolism , Pichia/metabolism , Recombinant Proteins/metabolism , Amino Acids/metabolism , Aminopeptidases/genetics , Aminopeptidases/metabolism , Culture Media/chemistry , Pichia/genetics , Recombinant Proteins/genetics , Sphingomonadaceae/enzymology , Sphingomonadaceae/genetics
16.
Bioorg Med Chem Lett ; 20(7): 2129-32, 2010 Apr 01.
Article in English | MEDLINE | ID: mdl-20207144

ABSTRACT

Methionine aminopeptidase (MetAP) is a promising target for the development of novel antibiotics. However, many potent inhibitors of the purified enzyme failed to show significant antibacterial activity. It is uncertain which divalent metal MetAP uses as its native cofactor in bacterial cells. Herein, we describe a cell-based assay that monitors the hydrolysis of a fluorogenic substrate by overexpressed MetAP in permeabilized Escherichia coli cells and its validation with a set of MetAP inhibitors. This cell-based assay is applicable to those cellular targets with poorly defined native cofactor, increasing the chances of identifying inhibitors that can inhibit the cellular target.


Subject(s)
Aminopeptidases/antagonists & inhibitors , Aminopeptidases/metabolism , Anti-Bacterial Agents/chemistry , Anti-Bacterial Agents/pharmacology , Drug Evaluation, Preclinical/methods , Escherichia coli/drug effects , Escherichia coli/enzymology , Aminopeptidases/genetics , Enzyme Inhibitors/chemistry , Enzyme Inhibitors/pharmacology , Escherichia coli/genetics , Methionyl Aminopeptidases , Up-Regulation
17.
J Membr Biol ; 215(2-3): 105-10, 2007 Feb.
Article in English | MEDLINE | ID: mdl-17415608

ABSTRACT

The monoclonal antibody to the beta-subunit of H(+)/K(+)-ATPase (mAbHKbeta) cross-reacts with a protein that acts as a molecular chaperone for the structural maturation of sarcoplasmic reticulum (SR) Ca(2+)-ATPase. We partially purified a mAbHKbeta-reactive 65-kDa protein from Xenopus ovary. After in-gel digestion and peptide sequencing, the 65-kDa protein was identified as methionine aminopeptidase II (MetAP2). The effects of MetAP2 on SR Ca(2+)-ATPase expression were examined by injecting the cRNA for MetAP2 into Xenopus oocytes. Immunoprecipitation and pulse-chase experiments showed that MetAP2 was transiently associated with the nascent SR Ca(2+)-ATPase. Synthesis of functional SR Ca(2+)-ATPase was facilitated by MetAP2 and prevented by injecting an antibody specific for MetAP2. These results suggest that MetAP2 acts as a molecular chaperone for SR Ca(2+)-ATPase synthesis.


Subject(s)
Aminopeptidases/metabolism , Sarcoplasmic Reticulum Calcium-Transporting ATPases/metabolism , Amino Acid Sequence , Aminopeptidases/chemistry , Aminopeptidases/genetics , Animals , Female , Immunoprecipitation , Methionyl Aminopeptidases , Microinjections , Molecular Chaperones/chemistry , Molecular Chaperones/genetics , Molecular Chaperones/metabolism , Molecular Sequence Data , Oocytes/metabolism , Protein Binding , RNA, Complementary/administration & dosage , RNA, Complementary/genetics , Rabbits , Sarcoplasmic Reticulum Calcium-Transporting ATPases/chemistry , Sarcoplasmic Reticulum Calcium-Transporting ATPases/genetics , Xenopus laevis
18.
Chembiochem ; 7(3): 506-14, 2006 Mar.
Article in English | MEDLINE | ID: mdl-16470765

ABSTRACT

The activity of the aminopeptidase P from Escherichia coli in hydrolyzing a series of organophosphonate sarin analogues (1-6) was evaluated. The enzymatic rates of hydrolysis for methylphosphonate 1 with a methoxy group attached to the phosphorus center were 7- to 15-fold higher than those for the corresponding analogues 2-6. Double mutant R153W/R370L was able to hydrolyze the S(p) enantiomer of racemic 1 at a considerable rate. This mutant allowed the preparation of the R(p) isomer of the sarin analogue 1. All the mutants, R370L, R153A, W88L, R153L/R370L, and R153W/R370L, preferred the formation of (S(p))-8 to that of the corresponding (R(p))-8 enantiomer and displayed a better enantiomeric excess of products, by 1.4- to 2-fold as compared to the wild-type enzyme. Enzymatic hydrolysis of O,O-diisopropyl-p-nitrophenyl phosphate (9) in H(2) (18)O led to the formation of the (18)O-labeled O,O-diisopropyl phosphate product and confirmed that the catalytic reaction starts with cleavage of the P--O bond. From chemical and kinetic studies, the utilization of an optically pure S(p) enantiomer of O-methyl-p-nitrophenyl methylphosphonothioate (S(p))-MNMPT, 7) has demonstrated that the enzymatic reaction proceeds through a displacement mechanism and generates a chiral product in situ with an inversion of stereochemical configuration at the phosphorus atom. The results also lead to the conclusion that alteration of the active site through site-directed mutagenesis can result in a preference for (S(p))-MNMPT (7) rather than the R(p) isomer.


Subject(s)
Aminopeptidases/metabolism , Phosphorus/chemistry , Sarin/metabolism , Aminopeptidases/genetics , Aminopeptidases/isolation & purification , Base Sequence , Catalysis , Crystallography, X-Ray , DNA Primers , Electrophoresis, Polyacrylamide Gel , Hydrolysis , Mass Spectrometry , Nuclear Magnetic Resonance, Biomolecular , Organophosphorus Compounds/chemistry , Organophosphorus Compounds/metabolism , Sarin/analogs & derivatives , Sarin/chemistry , Stereoisomerism
19.
FEBS J ; 273(24): 5574-88, 2006 Dec.
Article in English | MEDLINE | ID: mdl-17212776

ABSTRACT

A single membrane-bound aminopeptidase N (APN) occurs in the pea aphid (Acyrthosiphon pisum Harris) midgut, with a pH optimum of 7.0, pI of 8.1 and molecular mass of 130 kDa. This enzyme accounts for more than 15.6% of the total gut proteins. After being solubilized in detergent, APN was purified to homogeneity. The enzyme is a glycoprotein rich in mannose residues, which binds the entomotoxic lectins of the concanavalin family. The internal sequence of APN is homologous with a conservative domain in APNs, and degenerated primers of highly conserved APN motifs were used to screen a gut cDNA library. The complete sequence of APN has standard residues involved in zinc co-ordination and catalysis and a glycosyl-phosphatidylinositol anchor, as in APNs from Lepidoptera. APN has a broad specificity towards N-terminal amino acids, but does not hydrolyze acidic aminoacyl-peptides, thus resembling the mammalian enzyme (EC 3.4.11.2). The kcat/Km ratios for different di-, tri-, tetra-, and penta-peptides suggest a preference for tripeptides, and that subsites S1, S2' and S3' are pockets able to bind bulky aminoacyl residues. Bestatin and amastatin bound APN in a rapidly reversible mode, with Ki values of 1.8 microM and 0.6 microM, respectively. EDTA inactivates this APN (k(obs) 0.14 M(-1) x s(-1), reaction order of 0.44) at a rate that is reduced by competitive inhibitors. In addition to oligopeptide digestion, APN is proposed to be associated with amino-acid-absorption processes which, in contrast with aminopeptidase activity, may be hampered on lectin binding.


Subject(s)
Aminopeptidases/isolation & purification , Aminopeptidases/metabolism , Aphids/enzymology , Digestive System/enzymology , Mannose-Binding Lectins/metabolism , Amino Acid Sequence , Aminopeptidases/genetics , Animals , Aphids/cytology , Base Sequence , Binding Sites , Binding, Competitive , DNA, Complementary/biosynthesis , DNA, Complementary/genetics , Kinetics , Lepidoptera/enzymology , Mannose-Binding Lectins/pharmacology , Molecular Sequence Data , Phylogeny , Sequence Alignment , Substrate Specificity
20.
Int J Parasitol ; 35(14): 1577-85, 2005 Dec.
Article in English | MEDLINE | ID: mdl-16216247

ABSTRACT

An aminopeptidase full-length cDNA (Hg-amp-1) was cloned from the adult female soybean cyst nematode Heterodera glycines by heterologous screening of a cDNA library with a Caenorhabditis elegans EST sequence. The predicted open reading frame encoded an 882-amino acid protein containing the conserved zinc-binding domain and GAMEN motif that are characteristic of M1 family aminopeptidases. The putative protein lacks any subcellular targeting signals and displays strong similarity to puromycin-sensitive aminopeptidases from C. elegans, Drosophila and mammals. Hg-amp-1 is expressed in juvenile nematodes and both male and female adults, with highest expression in gravid females. In situ mRNA hybridisation localised the Hg-amp-1 transcript to the genital primordium of pre-parasitic juvenile nematodes and the reproductive tract of adult females. Suppression of Hg-amp-1 transcript level by RNA-interference led to a 61% reduction in the number of female nematodes parasitising soybean roots 21 days post infection with infective juvenile nematodes that had been exposed to double-stranded RNA.


Subject(s)
Aminopeptidases/genetics , DNA, Complementary/genetics , DNA, Helminth/genetics , Tylenchoidea/enzymology , Amino Acid Sequence , Animals , Base Sequence , Blotting, Southern , Caenorhabditis elegans/genetics , Cloning, Molecular , Drosophila/genetics , Female , Gene Expression , Gene Library , Humans , In Situ Hybridization , Life Cycle Stages , Male , Mice , Molecular Sequence Data , Nematode Infections/enzymology , Plant Diseases/parasitology , RNA Interference , Reverse Transcriptase Polymerase Chain Reaction , Sequence Homology, Amino Acid , Glycine max/parasitology , Tylenchoidea/genetics
SELECTION OF CITATIONS
SEARCH DETAIL